A 59-year-old man with a history of hypertrophic cardiomyopathy, kidney transplantation, and unusual multifocal ischemic lesions in the cerebral white matter visited our hospital for resuscitated cardiac arrest. Electrocardiogram and 2D-echocardiography demonstrated concentric hypertrophy (left ventricular wall thickness 23-24mm) and left ventricular systolic dysfunction (ejection fraction 44%) (Figure 1 and Supplementary Videos 1-3) . Endomyocardial biopsy showed enlarged, irregular-shaped, lipid-laden cardiomyocytes (Figure 2) .
form of FD and measured the patient's plasma GLA level and the enzyme activity. The plasma GLA level was 4.4 nmol/hr/mg protein (reference range=35-100 nmol/hr/mg protein) and the enzyme activity was 68.3% (reference range=85-95%). Both next-generation and Sanger sequencing of the GLA gene identified a novel mutation (c.775C>T [p.Pro259Ser]) at exon 5 ( Figure 3A) . The pedigree did not provide any more diagnostic clues ( Figure 3B) .
The mutation was not found in known public database of control subjects, 2) and a different mutation at the same amino acid residue had been reported before.
3) The genetic variation was located in a functionally critical domain and we found multiple computational evidences supporting the deleterious effect of the genetic variation (Supplementary Table 1 ). Combining these findings to pathogenicity criteria by the American College of Medical Genetics and Genomics, 4) the novel mutation c.775C>T (p.Pro259Ser) was considered to be likely pathogenic and we concluded the patient had a variant form of FD.
SUPPLEMENTARY MATERIALS

Supplementary Video 1
The parasternal long axis view of transthoracic echocardiography of the patient.
Click here to view
Supplementary Video 2
The parasternal short axis view at the level of papillary muscles of transthoracic echocardiography of the patient.
Click here to view
